The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180, 3478-3484
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knapp, S.
Right arrow Articles by van der Poll, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knapp, S.
Right arrow Articles by van der Poll, T.

Lipoteichoic Acid-Induced Lung Inflammation Depends on TLR2 and the Concerted Action of TLR4 and the Platelet-Activating Factor Receptor

Sylvia Knapp1,*,{dagger},{ddagger}, Sonja von Aulock, Masja Leendertse*, Isabella Haslinger{dagger},{ddagger}, Christian Draing, Douglas T. Golenbock|| and Tom van der Poll*,§

* Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; {dagger} Center for Molecular Medicine, Austrian Academy of Sciences and {ddagger} Division of Infectious Diseases, Department of Internal Medicine 1, Medical University of Vienna, Vienna, Austria; § Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Biochemical Pharmacology, University of Konstanz, Konstanz, Germany; and || Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605

Lipoteichoic acid (LTA) is a major outer cell wall component of Gram-positive bacteria that has been implicated as an important factor in the inflammatory response following bacterial infection. In vitro data indicate roles for TLR2, platelet-activating factor receptor (PAFR), CD14, and LPS-binding protein (LBP) in cellular responsiveness to LTA, whereas the mechanisms contributing to LTA effects in vivo have never been investigated. Using mice deficient for LBP, CD14, TLR2, TLR4, or PAFR, we now examined the role of these molecules in pulmonary inflammation induced by highly purified LTA in vivo. Although pulmonary LBP increased dose-dependently following administration of LTA, the inflammatory response was unaltered in LBP–/– mice. TLR2 proved to be indispensable for the initiation of an inflammatory response, as polymorphonuclear cell influx, TNF-{alpha}, keratinocyte-derived chemokine, and MIP-2 release were abolished in TLR2–/– mice. Minor effects such as moderately decreased TNF-{alpha} and MIP-2 levels were observed in the absence of CD14, indicating a role for CD14 as a coreceptor. Quite surprisingly, the absence of TLR4 greatly diminished pulmonary inflammation and the same phenotype was observed in PAFR–/– animals. In contrast to all other mice studied, only TLR4–/– and PAFR–/– mice displayed significantly elevated IL-10 pulmonary concentrations. These data suggest that TLR2 is the single most important receptor signaling the presence of LTA within the lungs in vivo, whereas TLR4 and PAFR may influence lung inflammation induced by LTA either by sensing LTA directly or through recognition and signaling of endogenous mediators induced by the interaction between LTA and TLR2.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Address correspondence and reprint requests to Dr. Sylvia Knapp, Division of Infectious Diseases, Department of Internal Medicine 1, Center for Molecular Medicine of the Austrian Academy of Sciences, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. E-mail address: sylvia.knapp{at}meduniwien.ac.at

2 Abbreviations used in this paper: LTA, lipoteichoic acid; PMN, polymorphonuclear cell; LBP, LPS-binding protein; PAFR, platelet-activating factor receptor; BAL, bronchoalveolar lavage; BALF, BAL fluid; AM, alveolar macrophage; HEK, human embryonic kidney; i.n., intranasal(ly); KC, keratinocyte-derived chemokine; MPO, myeloperoxidase; n.s., not significant.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Poole, T. A. Wyatt, P. J. Oldenburg, M. K. Elliott, W. W. West, J. H. Sisson, S. G. Von Essen, and D. J. Romberger
Intranasal organic dust exposure-induced airway adaptation response marked by persistent lung inflammation and pathology in mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L1085 - L1095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Hajishengallis, M. Wang, G. J. Bagby, and S. Nelson
Importance of TLR2 in Early Innate Immune Response to Acute Pulmonary Infection with Porphyromonas gingivalis in Mice
J. Immunol., September 15, 2008; 181(6): 4141 - 4149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.